FRANKIE STANLEY: Open Payments
NPI 1053625012 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 17 payments from 7 companies in 2025. Trend: 2023 $73 · 2024 $221 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $91 |
| Supernus Pharmaceuticals, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $29 |
| Tris Pharma Inc | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: Qelbree, CAPLYTA, INVEGA SUSTENNA, Auvelity, SPRAVATO, REXULTI, Dyanavel XR, VRAYLAR.
Industry payments across MS — which companies pay providers there.
